| Financial Year |
March 31 2023 |
| Monetary Funds |
793,429,126.37 |
| Held-for-trading Financial Assets |
840,000,000.00 |
| Notes Receivable |
3,534,602.33 |
| Accounts Receivable |
1,584,805,988.93 |
| Advances to Suppliers |
12,214,886.81 |
| Other Receivables |
108,870,610.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
198,800,211.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,752,271.16 |
| Other Current Assets |
2,842,623.25 |
| Total Current Assets |
3,663,951,114.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
163,991,293.90 |
| Long-term Equity Investment |
8,262,477.82 |
| Investment Properties |
40,405,970.57 |
| Fixed Assetes |
125,528,678.01 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,062,584.72 |
| R&D expenses |
55,793,154.33 |
| Goodwill |
440,779,441.04 |
| Long-Term Deferred and Prepaid Expenses |
6,104,286.66 |
| Deferred Income Tax Assets |
71,233,644.50 |
| Other Non-Current Assets |
5,130,000.00 |
| Sub-Total of Non-Current Assets |
1,101,465,512.74 |
| Total Assets |
4,765,416,627.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,749,315.80 |
| Accounts Payable |
492,406,428.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,691,017.11 |
| Taxes Payable |
47,851,692.42 |
| Interest Payable |
-- |
| Dividend Payable |
4,796,790.00 |
| Other payables |
61,441,964.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,014,063.86 |
| Other Current Liabilities |
30,246,334.36 |
| Sub-Total of Current Liabilities |
736,321,218.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,203,102.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
17,181,000.00 |
| Deferred Income Tax Liabilities |
3,180,231.58 |
| Other Non-Current Liabilities |
100,290,889.65 |
| Sub-Total of Non-Current Liabilities |
137,986,863.15 |
| Total Liabilities |
874,308,081.89 |
| Paid-In Capital(Or Share Stock) |
510,533,465.00 |
| Capital Surplus |
1,970,995,063.26 |
| Surplus Reserve |
131,852,335.41 |
| LESS:Treasury Stock |
50,395,141.93 |
| Undistributed Profits |
1,321,578,319.21 |
| Minority Stockholder's Interest |
6,544,504.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,884,564,040.95 |
| Owner's Equity（Stockholder's Equity） |
3,891,108,545.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,765,416,627.24 |
